Swedish Pharmaceuticals & Biotech Strong Balance Sheet Stocks

Chosa Oncology

Market Cap: SEK 34.4m

Develops oncology drugs for the treatment of cancer.

Annexin Pharmaceuticals

Market Cap: SEK 197.5m

A biotechnology company, develops drug candidates for the treatment of various cardiovascular diseases.

Vicore Pharma Holding

Market Cap: SEK 1.9b

A clinical-stage pharmaceutical company, develops therapies for the treatment of respiratory diseases in Sweden.

Inhalation Sciences Sweden

Market Cap: SEK 65.8m

Inhalation Sciences Sweden AB (publ) develops and sells labtech equipment for inhalation research.

Respiratorius

Market Cap: SEK 22.7m

A research company, develops drug candidates for the treatment of cancer, chronic obstructive pulmonary disease (COPD), and asthma.

Modus Therapeutics Holding

Market Cap: SEK 45.6m

A biotechnology company, develops a treatment for sepsis and septic shock in Sweden.

AcouSort

Market Cap: SEK 59.7m

A technology company, develops products and solutions for automated preparation of biological samples based on acoustofluidics technology for researchers and life science companies.

Lipigon Pharmaceuticals

Market Cap: SEK 17.8m

Develops drugs for lipid related diseases in Sweden.

Abera Bioscience

Market Cap: SEK 133.6m

A platform and vaccine development company, research, design, and develops vaccines and immunotherapies based on its proprietary vaccine delivery platform in Sweden and internationally.

Karolinska Development

Market Cap: SEK 253.6m

A venture capital firm specializing in investments in growth capital, seed stage, and early stage companies.

Camurus

Market Cap: SEK 34.6b

A biopharmaceutical company, develops and commercializes medicines for severe and chronic conditions in Europe, Australia, the United States, and internationally.

Bonesupport Holding

Market Cap: SEK 19.7b

An orthobiologics company, develops and sells injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally.

Dextech Medical

Market Cap: SEK 77.6m

Engages in the development of drug candidates with application in urological oncology, primarily prostate cancer.

Genovis AB (publ.)

Market Cap: SEK 1.6b

Develops and sells tools for the development of new treatment methods and diagnostics for customers in the pharmaceutical and research industries.

Flerie

Market Cap: SEK 3.2b

A venture capital firm specializing in early-stage investments.

OncoZenge

Market Cap: SEK 52.1m

A pharmaceutical company, engages in the development of treatment for pain relief in patients suffering from oral pain caused by radiation therapy and chemotherapy for cancer in Sweden.

Promimic

Market Cap: SEK 517.6m

Manufactures, markets, and sells biomaterials for improved osseointegration for orthopedic and dental implants markets.

SynAct Pharma

Market Cap: SEK 947.8m

A clinical stage biotechnology company, researches and develops medicines for the treatment of inflammatory diseases in Sweden.

BioArctic

Market Cap: SEK 17.2b

Develops biological drugs for patients with disorders of the central nervous system in Sweden.

BioGaia

Market Cap: SEK 10.1b

A healthcare company, provides probiotic products worldwide.

BioInvent International

Market Cap: SEK 2.0b

A clinical-stage company, discovers, and develops novel immuno-modulatory antibodies for the treatment of cancer in Sweden, Europe, the United States, and internationally.

Cessatech

Market Cap: DKK 227.2m

A pharmaceutical company, develops and commercializes medicines for the treatment of pediatric acute pain in Denmark.

Alzinova

Market Cap: SEK 172.1m

A biopharmaceutical company, develops immunotherapies treatment for Alzheimer’s disease in Sweden.

CombiGene

Market Cap: SEK 48.9m

Engages in the development of gene therapy for severe life-altering diseases in Sweden.

Dicot Pharma

Market Cap: SEK 660.1m

Engages in the development of pharmaceutical products in Sweden.

Cinclus Pharma Holding

Market Cap: SEK 487.7m

A clinical stage pharmaceutical company, engages in the development of the drug candidate for the treatment of related diseases.

ExpreS2ion Biotech Holding

Market Cap: SEK 52.8m

Through its subsidiary, ExpreS2ion Biotechnologies ApS, researches and develops preventive and therapeutic vaccine products in the Nordics and internationally.

Biotage

Market Cap: SEK 11.3b

Provides solutions and products in the areas of drug discovery and development, analytical testing, and water and environmental testing.

Biosergen

Market Cap: SEK 70.0m

A biotech company, develops antifungal products.

Infant Bacterial Therapeutics

Market Cap: SEK 802.9m

Operates as a clinical stage pharmaceutical company develops and markets drugs to prevent serious neonatal diseases affecting premature infants in Sweden.

Isofol Medical

Market Cap: SEK 304.6m

A clinical stage biotech company, develops, commercializes, and sells oncology drugs in Sweden and internationally.

Enorama Pharma

Market Cap: SEK 169.3m

A pharmaceutical company, develops, manufactures, and sells medicated chewing gum containing proven generic substances in Sweden.

Guard Therapeutics International

Market Cap: SEK 265.2m

A pharmaceutical company, identifies, develops, and commercializes therapies for the diagnosis and treatment of acute kidney injuries in Sweden.

MedCap

Market Cap: SEK 6.4b

A private equity firm specializing in investments in secondary direct, later stage, industry consolidation, add-on acquisitions, growth capital, middle market, mature, turnarounds, buyout.

Intervacc

Market Cap: SEK 349.0m

Develops novel veterinary vaccines for animals in Sweden.

Saniona

Market Cap: SEK 979.8m

A clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of treatments for rare disease patients in Sweden, Germany, Denmark, the United Kingdom, and Mexico.